Recently the USFDA approved sarecycline, a tetracycline-class drug for the treatment of acne vulgaris in patients aged nine years and more. This drug was approved after it showed positive results in clinical trials. Introduction : Acne vulgaris is one of the most common skin disorders in teenagers and adults. However, this skin condition can be daunting and may take a toll on self-esteem, especially among teenagers.
Dermatologists find it hard to treat acne in teenage patients as it is mainly triggered by hormonal changes. In recent years, due to a better understanding of acne’s pathophysiology, various combination drugs are under clinical investigations as new therapeutic options. In this regard, the FDA has approved a new, first-of-its-kind tetracycline-derived antibiotic called sarecycline for the treatment of nodular acne vulgaris. The characteristics of the drug are listed in the…
